BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36599466)

  • 81. [Lung lymphangioleiomyomatosis (LAM)].
    Cukić V; Lovre V; Beslić S; Bilalović N; Guska S
    Med Arh; 2008; 62(3):180-2. PubMed ID: 18822952
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.
    Harari S; Spagnolo P; Cocconcelli E; Luisi F; Cottin V
    Curr Opin Pulm Med; 2018 Sep; 24(5):469-476. PubMed ID: 29927757
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings.
    Kirchner J; Stein A; Viel K; Dietrich CF; Thalhammer A; Schneider M; Jacobi V
    Eur Radiol; 1999; 9(1):49-54. PubMed ID: 9933379
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
    Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
    Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.
    Pacheco-Rodriguez G; Moss J
    Crit Rev Immunol; 2010; 30(4):387-94. PubMed ID: 20666708
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pulmonary Lymphangioleiomyomatosis: A Case Report and Literature Review.
    Sathirareuangchai S; Shimizu D; Vierkoetter KR
    Hawaii J Health Soc Welf; 2020 Jul; 79(7):224-229. PubMed ID: 32666056
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
    De Rosa N
    Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Pulmonary lymphangioleiomyomatosis (LAM)].
    Theegarten D; Hager T
    Pathologe; 2021 Feb; 42(1):35-39. PubMed ID: 33420570
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Case of Lymphangioleiomyomatosis (LAM) of the Lung in a Patient with a History of Breast Cancer.
    Koc-Günel S; Tekeli N; Smaczny C; Vogl T; Rohde G
    Am J Case Rep; 2019 Mar; 20():390-393. PubMed ID: 30905927
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
    Valencia JC; Steagall WK; Zhang Y; Fetsch P; Abati A; Tsukada K; Billings E; Hearing VJ; Yu ZX; Pacheco-Rodriguez G; Moss J
    Chest; 2015 Mar; 147(3):771-777. PubMed ID: 25411763
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.
    Steagall WK; Pacheco-Rodriguez G; Glasgow CG; Ikeda Y; Lin JP; Zheng G; Moss J
    Am J Pathol; 2013 Sep; 183(3):938-50. PubMed ID: 23867796
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis.
    Krencz I; Sebestyen A; Papay J; Jeney A; Hujber Z; Burger CD; Keller CA; Khoor A
    Hum Pathol; 2018 Sep; 79():199-207. PubMed ID: 29885404
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Extrapulmonary lymphangioleiomyomatosis presented as the asymptomatic retroperitoneal tumours--two cases report.
    Słodkowska J; Patera J; Breborowicz J; Jarzemska A; Korzeniewska-Kosela M; Siemiatkowska K; Radzikowska E; Przybylski G; Kozłowski W
    Pol J Pathol; 2006; 57(4):205-7. PubMed ID: 17285764
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Anesthetic management of a patient with lymphangioleiomyomatosis who developed respiratory failure post-operatively].
    Tsubaki K; Tomioka T; Arita H; Hanaoka K
    Masui; 2003 Jan; 52(1):49-51. PubMed ID: 12632621
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis.
    Clements D; Dongre A; Krymskaya VP; Johnson SR
    PLoS One; 2015; 10(5):e0126025. PubMed ID: 25978616
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The lung microbiome in end-stage Lymphangioleiomyomatosis.
    Ng J; Pacheco-Rodriguez G; Begley L; Huang YJ; Poli S; Perrella MA; Rosas IO; Moss J; El-Chemaly S
    Respir Res; 2021 Oct; 22(1):277. PubMed ID: 34702264
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
    Koba T; Arai T; Kitaichi M; Kasai T; Hirose M; Tachibana K; Sugimoto C; Akira M; Hayashi S; Inoue Y
    Respirology; 2018 Mar; 23(3):331-338. PubMed ID: 28960664
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
    von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
    Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Lung cancer and lymphangioleiomyomatosis: A common complication in an uncommon condition.
    Brims F
    Respirology; 2024 Jun; ():. PubMed ID: 38857971
    [No Abstract]   [Full Text] [Related]  

  • 100. Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells.
    Olatoke T; Wagner A; Astrinidis A; Zhang EY; Guo M; Zhang AG; Mattam U; Kopras EJ; Gupta N; Smith EP; Karbowniczek M; Markiewski MM; Wikenheiser-Brokamp KA; Whitsett JA; McCormack FX; Xu Y; Yu JJ
    Sci Adv; 2023 May; 9(19):eadf8549. PubMed ID: 37163604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.